Anticoagulants have been identified as the second most common drug associated with adverse events requiring treatment in the hospital emergency department. Based on medication error data compiled by the United States Pharmacopoeia (USP), warfarin has been identified as one of the 10 drugs most commonly involved in a medication error in the hospital. For these reasons, anticoagulants have and will continue to receive targeted attention during the coming years as part of medication safety initiatives from the Joint Commission, National Quality Forum (NQF), the Institute for Healthcare Improvement (IHI), and the Institute for Safe Medication Practices (ISMP). The Joint Commission has released its 2008 National Patient Safety Goals (NPSGs) that address strategies to reduce the likelihood of patient harm associated with the use of anticoagulation therapy.
fulfill, in part, the educational expectations for this NPSG 3e,
information is provided regarding the primary anticoagulants prescribed
for patients at Nationwide Children’s Hospital on the Regulatory Corner
insert in the November Physician envelope. If you have questions
regarding anticoagulation therapy or this NPSG, please contact Stacy
Ramga, Pharm.D., M.S., Pharmacy Clinical Coordinator at 722-2092 or
Rick McClead MD, Medical Director, Quality Improvement Services, at